Lupin has informed that it enclosed a Press Release as regards, appointment of Shahin Fesharaki as Global Chief Scientific Officer of the Company. This is a disclosure pursuant to Regulation 30 of the Listing Regulations.
The above information is a part of company’s filings submitted to BSE